Oncolytics Biotech Inc. (ONCY)
NASDAQ: ONCY · Real-Time Price · USD
0.954
-0.026 (-2.64%)
At close: Nov 22, 2024, 4:00 PM
0.950
-0.004 (-0.42%)
After-hours: Nov 22, 2024, 7:28 PM EST
Oncolytics Biotech Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 22, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 73 | 100 | 97 | 76 | 103 | 125 | |
| Market Cap Growth | -57.87% | 3.47% | 27.24% | -25.88% | -17.85% | 300.37% | |
| Enterprise Value | 60 | 70 | 73 | 39 | 82 | 116 | |
| PB Ratio | 10.12 | 4.80 | 4.94 | 2.67 | 5.29 | -1502.40 | |
| P/TBV Ratio | 10.12 | 4.80 | 4.94 | 2.67 | 5.29 | - | |
| Debt / Equity Ratio | 0.12 | 0.02 | 0.01 | 0.02 | 0.02 | -4.69 | |
| Quick Ratio | 2.57 | 8.24 | 8.15 | 15.37 | 11.56 | 1.14 | |
| Current Ratio | 2.99 | 9.01 | 9.05 | 16.69 | 12.45 | 1.47 | |
| Return on Equity (ROE) | -145.20% | -102.66% | -79.34% | -86.45% | -182.63% | -1088.23% | |
| Return on Assets (ROA) | -62.89% | -55.46% | -40.44% | -40.88% | -58.93% | -72.93% | |
| Return on Capital (ROIC) | -111.57% | -76.99% | -52.89% | -52.97% | -124.54% | -381.87% | |
| Earnings Yield | -27.92% | -20.98% | -18.95% | -27.32% | -17.20% | -20.43% | |
| FCF Yield | -24.78% | -21.51% | -17.86% | -23.59% | -16.89% | -12.29% | |
| Buyback Yield / Dilution | -17.93% | -16.53% | -8.44% | -32.66% | -82.22% | -38.22% | |
| Total Shareholder Return | -17.93% | -16.53% | -8.44% | -32.66% | -82.22% | -38.22% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.